HDRPFEpsilon Healthcare Limited
Price Chart
Loading chart...
About Epsilon Healthcare Limited (HDRPF)
Epsilon Healthcare Limited (HDRPF) is a Drug Manufacturers - Specialty & Generic company headquartered in Sydney, NSW, Australia whose shares trade over-the-counter on the Pink tier.
THC is at the forefront of developing a leading, diversified worldwide cannabis business, focused on the development and delivery of medicinal cannabis, manufacturing and distribution of hydroponics equipment, materials and nutrients. We aim to capitalise on the surging global cannabis market, generating significant near term value through our strategic assets, rapidly expanding these core businesses in 2017 and beyond.
HDRPF key facts
- Ticker symbol
- HDRPF
- Market tier
- Pink
- Sector
- Healthcare
- Headquarters
- Sydney, NSW, Australia
- Country of incorporation
- AU
- Estimated market cap
- $178.2K (as of Aug 1, 2025)
- Shares outstanding
- 127,267,572
- Reporting standard
- International Reporting: ASX - Australian Securities Exchange
- Audit status
- Audited
- Fiscal year end
- 6/30
Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with H
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Epsilon Healthcare Limited (HDRPF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Drug Manufacturers - Specialty & Generic Companies on OTC Markets
Other OTC-traded companies in Drug Manufacturers - Specialty & Generic:
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Social Media
Business Details
Stock Details
Loading modules...